FAP and neoplasm: Following 177Lu labeling, SPECT results demonstrated optimal tumor uptake and biodistribution of 177Lu-FAPI-46-EB in the high FAP-expressing HT1080.hFAP model, whereas showing poor tumor uptake and biodistribution in the moderately FAP-expressing HEK293.hFAP model.